These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3328044)

  • 1. [Molecular basis for constructing artificial immunogens].
    Khaitov RM
    Mol Gen Mikrobiol Virusol; 1987 Nov; (11):3-8. PubMed ID: 3328044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular bases for the construction of artificial immunogens.
    Khaitov RM
    Biomed Sci; 1990 Feb; 1(2):122-6. PubMed ID: 2102774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular bases for the construction of artificial immunogens and vaccines based on synthetic polyions.
    Khaitov RM
    Allergy Proc; 1995; 16(5):255-60. PubMed ID: 8566740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetic engineering and trends in the research on new vaccines].
    Hofnung M
    C R Seances Soc Biol Fil; 1988; 182(2):141-57. PubMed ID: 2461790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genetics of immune response and vaccines of tomorrow].
    Khaitov RM
    Vestn Ross Akad Med Nauk; 1999; (4):9-18. PubMed ID: 10377877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies of constructing recombinant vaccines.
    Sałamaszyńska-Guz A; Klimuszko D
    Pol J Vet Sci; 2009; 12(1):133-9. PubMed ID: 19459451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of new generation of vaccines based on structural conjugation of antigens and synthetic polymer immunomodulators].
    Khaitov RM
    Vopr Med Khim; 1997; 43(5):390-401. PubMed ID: 9446328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applying biotin-streptavidin binding for iscom (immunostimulating complex) association of recombinant immunogens.
    Wikman M; Friedman M; Pinitkiatisakul S; Hemphill A; Lövgren-Bengtsson K; Lundén A; Ståhl S
    Biotechnol Appl Biochem; 2005 Apr; 41(Pt 2):163-74. PubMed ID: 15296488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manipulation of the cellular binding properties of poliovirus: implications for non-target effects of recombinant vaccines.
    Whelan SP; Evans D; Almond JW
    Dev Biol Stand; 1995; 84():129-36. PubMed ID: 7796945
    [No Abstract]   [Full Text] [Related]  

  • 10. [Molecular construction of experimental combined vaccines].
    Lebedev LR; Sizov AA; Karpenko LI; Poryvaeva VA; Odegov AM
    Mol Gen Mikrobiol Virusol; 2002; (1):17-21. PubMed ID: 11904919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Versatile RHDV virus-like particles: incorporation of antigens by genetic modification and chemical conjugation.
    Peacey M; Wilson S; Baird MA; Ward VK
    Biotechnol Bioeng; 2007 Dec; 98(5):968-77. PubMed ID: 17546687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contributions of mass spectrometry to structural immunology.
    Downard KM
    J Mass Spectrom; 2000 Apr; 35(4):493-503. PubMed ID: 10797646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly immunogenic artificial complexes based on synthetic immunopotentiating polyions (artificial antigens and vaccines).
    Petrov RV; Khaitov RM
    Am J Reprod Immunol Microbiol; 1986 Mar; 10(3):105-10. PubMed ID: 2424324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing the immune response to foreign antigen expressed in recombinant BCG vaccines.
    Dennehy M; Williamson AL
    Vaccine; 2005 Jan; 23(10):1209-24. PubMed ID: 15652663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Artificial antigens for synthetic vaccines].
    Swidsinski A; Swidsinski S
    Z Arztl Fortbild (Jena); 1988; 82(1):7-14. PubMed ID: 3285604
    [No Abstract]   [Full Text] [Related]  

  • 16. Proteomics approaches towards antigen discovery and vaccine development.
    Klade CS
    Curr Opin Mol Ther; 2002 Jun; 4(3):216-23. PubMed ID: 12139306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetically engineered vaccines: problems and promises.
    Brown F; Dougan G; Snary D
    Microbiol Sci; 1984 Aug; 1(5):123-7. PubMed ID: 6444113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vaccines obtained by genetic engineering].
    Tron F
    Rev Prat; 1988 Jan; 38(1):45-9. PubMed ID: 3344394
    [No Abstract]   [Full Text] [Related]  

  • 19. Bacterial ghosts as carrier and targeting systems for mucosal antigen delivery.
    Jalava K; Eko FO; Riedmann E; Lubitz W
    Expert Rev Vaccines; 2003 Feb; 2(1):45-51. PubMed ID: 12901596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant Salmonella vectors in vaccine development.
    Curtiss R; Kelly SM; Tinge SA; Tacket CO; Levine MM; Srinivasan J; Koopman M
    Dev Biol Stand; 1994; 82():23-33. PubMed ID: 7958478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.